Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

11084	Companies
243306	Keywords
171464	Articles
131024	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 11/17/2025 at 14:00, 10 months 10 days ago

Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue
Jaguar Health, Inc. reports proof-of-concept trial shows crofelemer potential for MVID patients, financial results revealed, FDA meeting outcome, and upcoming investor webcast

Financial Results Crofelemer Investor Webcast Jaguar Health Inc. MVID
BRIEF

published on 11/14/2025 at 15:05, 10 months 13 days ago

Jaguar Health organisera une webdiffusion pour les investisseurs le 17 novembre 2025.

Rapport Financier Jaguar Health Magdalena Biosciences Webinaire Pour Les Investisseurs Médicaments Gastro-intestinaux
BRIEF

published on 11/14/2025 at 15:05, 10 months 13 days ago

Jaguar Health to Host Investor Webcast on November 17, 2025

Financial Report Investor Webcast Jaguar Health Magdalena Biosciences Gastrointestinal Medicines
PRESS RELEASE

published on 11/14/2025 at 15:00, 10 months 13 days ago

Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates
Jaguar Health, Inc. (NASDAQ:JAGX) to file Earnings Report on Form 10-Q for quarter ended September 30, 2025. Investor webcast on November 17, 2025 at 8:30 a.m. Eastern to review financials and provide corporate updates

Earnings Report Investor Webcast Jaguar Health Form 10-Q NASDAQ:JAGX
BRIEF

published on 11/13/2025 at 15:05, 10 months 14 days ago

Jaguar Health met en avant des résultats d'étude prometteurs concernant le crofélémère dans l'insuffisance intestinale pédiatrique

Crofelemer Essai Clinique Insuffisance Intestinale Chez L'enfant Maladie À Inclusions Microvillositaires Soutien Parentéral
BRIEF

published on 11/13/2025 at 15:05, 10 months 14 days ago

Jaguar Health Highlights Promising Study Results for Crofelemer in Pediatric Intestinal Failure

Crofelemer Microvillus Inclusion Disease Clinical Trial Pediatric Intestinal Failure Parenteral Support
PRESS RELEASE

published on 11/13/2025 at 15:00, 10 months 14 days ago

Jaguar Health Provides Recap of November 8, 2025 Presentation on Groundbreaking Results of Proof-of-Concept Study of Crofelemer for Treatment of Pediatric Intestinal Failure at NASPGHAN Annual Meeting
Crofelemer shows promising results in reducing total parenteral support for MVID patients, presented at NASPGHAN. Jaguar Health's investigation explores breakthrough benefits for pediatric patients with intestinal failure

Crofelemer Jaguar Health MVID Intestinal Failure NASPGHAN
BRIEF

published on 11/06/2025 at 15:05, 10 months 21 days ago

Jaguar Health présente des résultats d'essai prometteurs pour le traitement de l'insuffisance intestinale pédiatrique

Syndrome De L'intestin Court Insuffisance Intestinale Chez L'enfant Procès Crofelemer Réduction Du Soutien Parentéral Maladie À Inclusions Microvillositaires
BRIEF

published on 11/06/2025 at 15:05, 10 months 21 days ago

Jaguar Health Presents Promising Trial Results for Pediatric Intestinal Failure Treatment

Microvillus Inclusion Disease Short Bowel Syndrome Crofelemer Trial Pediatric Intestinal Failure Parenteral Support Reduction
PRESS RELEASE

published on 11/06/2025 at 15:00, 10 months 21 days ago

REMINDER: Initial Groundbreaking Results of Proof-of-Concept Study of Jaguar Health's Crofelemer for Treatment of Pediatric Intestinal Failure to be Presented November 8, 2025 at North American Society for Pediatric Gastroenterology, Hepatology and Nutrit
Ongoing trial of crofelemer in UAE shows reduction in parenteral support for pediatric intestinal failure patients. Breakthrough in MVID and SBS-IF treatment

Crofelemer MVID SBS-IF Intestinal Failure UAE Trial

Accesswire

Published on 09/26/2026 at 01:00, 1 day 21 hours ago

Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 1 day 21 hours ago

Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 1 day 23 hours ago

Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days 4 hours ago

Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 7 hours ago

HM Exploration Provides Program Update for the Lewis Pilley's Project

View all ACCESSWIRE

EQS Group

Published on 09/27/2026 at 17:05, 5 hours 2 minutes ago

Saudi Tourism Authority Concludes Monaco Yacht Show 2026 with Major Milestones for Saudi Red Sea Yachting
Published on 09/26/2026 at 15:30, 1 day 6 hours ago

QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 1 day 6 hours ago

QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 1 day 6 hours ago

Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 1 day 14 hours ago

Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe

Les Echos

Published on 09/26/2026 at 07:00, 1 day 15 hours ago

Groupe DLSI - Résultat 1er semestre 2026
Published on 09/25/2026 at 18:00, 2 days 4 hours ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 18:00, 2 days 4 hours ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 17:45, 2 days 4 hours ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 2 days 4 hours ago

Availability of the 2026 half-year financial report

View all LES ECHOS COMFI WIRE